| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Chief Financial Officer
1 company
Sean Grant is Chief Financial Officer at VERA. Sean Grant's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $3.5M at current prices.
Our model assigns Sean Grant a middling insider score of 56/100, based on 5 past trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +16.9%.
The VERA filings lean toward selling, a net 99,141 shares.
Sean Grant has 13 Form 4 filings on record from June 2021 to February 2026, all as Chief Financial Officer at Vera Therapeutics (VERA), 2021–2026.
The 42 reported transactions were 20 open-market sales, 6 option or other derivative awards, 6 open-market purchases and 5 gifts, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $251K and 2 sales worth about $4.9M.
The largest open-market purchase was 14,285 shares of VERA at an average $7.00 on February 6, 2022, about $100K. Twelve months later VERA was down 66%.
The largest open-market sale was 118,477 shares of VERA at an average $39.58 on April 3, 2024, about $4.7M. Twelve months later VERA was down 43%.
Neither of the two sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | VERA Vera Therapeutics, Inc. | Chief Financial Officer | Sell | 4,949 | $41.98 | $207,778.32 | -4.2% | -18.4% | - | |
| Apr 3, 2024 | VERA Vera Therapeutics, Inc. | Chief Financial Officer | Sale+OE | 118,477 | $39.58 | $4,689,721.58 | -96.0% | -11.8% | -42.6% | |
| Jun 23, 2023 | VERA Vera Therapeutics, Inc. | Chief Financial Officer | Buy | 5,000 | $16.60 | $83,000.00 | +504.0% | -13.7% | +107.8% | |
| Jun 15, 2022 | VERA Vera Therapeutics, Inc. | Chief Financial Officer | Buy | 5,000 | $13.60 | $68,004.00 | -124.8% | +49.4% | -9.1% | |
| Feb 6, 2022 | VERA Vera Therapeutics, Inc. | Chief Financial Officer | Buy | 14,285 | $7.00 | $99,995.00 | +40.1% | -9.1% | -65.8% |